INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Results

6,670 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
30
Mike KellyRSpouse
MDMississippi St Ref Go P/R 10/1/27 5% due 10/1/31
Sale
SELL$50K – $100KAug 17, 2026
Page 29 of 167
← PrevNext →
Sep 8, 2026
traded Aug 17, 2026
+22d
House PTR

Evidence

30
Mike KellyRSpouse
NDNew Jersey St 19 GO Emer Go 5% due 6/1/28
Sale
SELL$50K – $100KAug 28, 2026Sep 8, 2026
traded Aug 28, 2026
+11dHouse PTR

Evidence

31
David J. TaylorRSelf
MSFTMICROSOFT CORP
Sale
SELL$1,001 – $15KAug 26, 2026Sep 5, 2026
traded Aug 26, 2026
+10dHouse PTR

Evidence

52
LA
Lacerte Rene A.Director, CEO
BILLBILL Holdings, Inc.
Open-market sale
SELL$4.90M
100.9K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

51
Gilbert Ray Cisneros, Jr.DSelf
FNFabrinet
Sale
SELL$15K – $50KJul 16, 2026Sep 4, 2026
traded Jul 16, 2026
+50dHouse PTR

Evidence

50
SB
Spetzler David BaxleyPresident
CAICaris Life Sciences, Inc.
Open-market sale
SELL$9.73M
393.1K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

48
LA
Lacerte Rene A.Director, CEO
BILLBILL Holdings, Inc.
Open-market sale
SELL$1.31M
27.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

48
LA
Lacerte Rene A.Director, CEO
BILLBILL Holdings, Inc.
Open-market sale
SELL$1.94M
40.4K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

46
SB
Spetzler David BaxleyPresident
CAICaris Life Sciences, Inc.
Open-market sale
SELL$2.15M
84.9K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

46
CV
Coloma Jason VDirector, Chief Executive Officer
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$293K
11.3K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

46
CV
Coloma Jason VDirector, Chief Executive Officer
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$260K
9,852 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

44
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$3.52M
15.5K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

44
LA
Lacerte Rene A.Director, CEO
BILLBILL Holdings, Inc.
Open-market sale
SELL$1.18M
24.4K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

43
CP
Courtney PhillipsGC and Corp. Secretary
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$52K
1,990 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

42
Gilbert Ray Cisneros, Jr.DSelf
LITELumentum Holdings Inc.
Sale
SELL$1,001 – $15KJul 17, 2026Sep 4, 2026
traded Jul 17, 2026
+49dHouse PTR

Evidence

42
Gilbert Ray Cisneros, Jr.DSelf
DDDuPont de Nemours, Inc.
Sale
SELL$1,001 – $15KJul 17, 2026Sep 4, 2026
traded Jul 17, 2026
+49dHouse PTR

Evidence

42
WA
Ware J. AnthonyDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Open-market sale
SELL$1.76M
39.3K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

42
Gilbert Ray Cisneros, Jr.DSelf
VZVERIZON COMMUNICATIONS INC
Partial sale
SELL$1,001 – $15KJul 17, 2026Sep 4, 2026
traded Jul 17, 2026
+49dHouse PTR

Evidence

42
Gilbert Ray Cisneros, Jr.DSelf
EAElectronic Arts Inc. - Common Stock
Partial sale
SELL$1,001 – $15KJul 17, 2026Sep 4, 2026
traded Jul 17, 2026
+49dHouse PTR

Evidence

42
Gilbert Ray Cisneros, Jr.DSelf
AVAVAeroVironment Inc
Sale
SELL$1,001 – $15KJul 2, 2026Sep 4, 2026
traded Jul 2, 2026
+64dHouse PTR

Evidence

41
Gilbert Ray Cisneros, Jr.DSelf
BABAAlibaba Group Holding Ltd
Sale
SELL$100K – $250KJul 24, 2026Sep 4, 2026
traded Jul 24, 2026
+42dHouse PTR

Evidence

41
LA
Lacerte Rene A.Director, CEO
BILLBILL Holdings, Inc.
Open-market sale
SELL$511K
10.6K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

41
Gilbert Ray Cisneros, Jr.DSelf
STZCONSTELLATION BRANDS, INC.
Sale
SELL$1,001 – $15KJul 17, 2026Sep 4, 2026
traded Jul 17, 2026
+49dHouse PTR

Evidence

41
LA
Lacerte Rene A.Director, CEO
BILLBILL Holdings, Inc.
Open-market sale
SELL$565K
11.8K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

40
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$1.87M
8,277 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

40
SJ
Simon JoshDirector, Chief Executive Officer
FNKOFunko, Inc.
Open-market sale
SELL$786K
136.3K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

40
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$133K
5,130 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

40
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$118K
4,481 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

40
CP
Courtney PhillipsGC and Corp. Secretary
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$46K
1,738 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

39
TB
Turner Matthew BakerPRES., PATIENT AFFORDABILITY
PAYSPaysign, Inc.
Open-market sale
SELL$63K
15.1K sh
Feb 3, 2026Sep 4, 2026
traded Feb 3, 2026
+213dSEC Form 4

Evidence

39
CK
Cunningham Bradley KramerChief Technology Officer
PAYSPaysign, Inc.
Open-market sale
SELL$73K
10.0K sh
May 29, 2026Sep 4, 2026
traded May 29, 2026
+98dSEC Form 4

Evidence

38
NT
Notman TaliCHIEF REVENUE OFFICER
FROGJFrog Ltd
Open-market sale
SELL$1.73M
19.2K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

38
PA
Pollitzer AdamDirector, Chief Executive Officer
NMIHNMI Holdings, Inc.
Open-market sale
SELL$7.75M
172.7K sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

38
SA
Shauli AviChief Technology Officer
RSKDRISKIFIED LTD.
Open-market sale
SELL$193K
30.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

36
CV
Coloma Jason VDirector, Chief Executive Officer
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$37K
1,375 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

36
SJ
Simon JoshDirector, Chief Executive Officer
FNKOFunko, Inc.
Open-market sale
SELL$267K
45.5K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

36
Gilbert Ray Cisneros, Jr.DSelf
IBMINTERNATIONAL BUSINESS MACHINES CORP
Sale
SELL$1,001 – $15KJul 17, 2026Sep 4, 2026
traded Jul 17, 2026
+49dHouse PTR

Evidence

36
SC
Spice Adam C.Chief Financial Officer
RKLBRocket Lab Corp
Open-market sale · 10b5-1 plan
SELL$4.59M
72.9K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

36
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$74K
2,800 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

36
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$83K
3,207 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence